125 results on '"Luescher I"'
Search Results
2. CD8 T cell function and cross-reactivity explored by stepwise increased peptide-HLA versus TCR affinity
Catalog
Books, media, physical & digital resources
3. Transient Expression of a Soluble and Secreted form of Heterodimeric T-Cell Receptor in Hek-293
4. Further Analysis of the Role of MHC Molecules in Antigen Presentation
5. The efficiency of antigen recognition by CTL is determined by the frequency of serial TCR engagement
6. The Efficiency of Antigen Recognition by CD8+ CTL Clones Is Determined by the Frequency of Serial TCR Engagement
7. Analysis, Isolation, and Activation of Antigen-Specific CD4 + and CD8+ T Cells by Soluble MHC-Peptide Complexes
8. Immunological Properties of Hapten-Peptide Conjugates: The Effect of Size, Lipophilic Substituents and Haptenic Distance on Tolerogenicity and Anaphylactogenicity
9. Transient Expression of a Soluble and Secreted form of Heterodimeric T-Cell Receptor in Hek-293
10. MHC class II/ESO tetramer-based generation of in vitro primed anti-tumor T-helper lines for adoptive cell therapy of cancer
11. A peptide encoded by human gene MAGE-3 and presented by HLA-B44 induces cytolytic T lymphocytes that recognize tumor cells expressing MAGE-3.
12. Crystal structure of HLA-A2*0201 in complex with a decameric altered peptide ligand from the MART-1/Melan-A
13. Aberrant recognition of epitope variants by CTL is controlled by CD8
14. Covalent assembly of a soluble T cell receptor-peptide-major histocompatibility class I complex.
15. Photoaffinity labeling of the T cell receptor on living cytotoxic T lymphocytes.
16. Differential T cell receptor photoaffinity labeling among H-2Kd restricted cytotoxic T lymphocyte clones specific for a photoreactive peptide derivative. Labeling of the alpha-chain correlates with J alpha segment usage.
17. Direct binding of peptides to MHC class I molecules on living cells. Analysis at the single cell level.
18. Highly diverse T cell recognition of a single Plasmodium berghei peptide presented by a series of mutant H-2Kd molecules.
19. A nonapeptide encoded by human gene MAGE-1 is recognized on HLA-A1 by cytolytic T lymphocytes directed against tumor antigen MZ2-E.
20. Immunization with synthetic peptides containing a defined malaria epitope induces a highly diverse cytotoxic T lymphocyte response. Evidence that two peptide residues are buried in the MHC molecule.
21. Interaction of antigenic peptides with MHC class I molecules on living cells studied by photoaffinity labeling.
22. H-2Kd-restricted antigenic peptides share a simple binding motif.
23. The sites in the I-Ak histocompatibility molecule photoaffinity labeled by an immunogenic lysozyme peptide.
24. Phospholipids enhance the binding of peptides to class II major histocompatibility molecules.
25. T cell recognition of hapten. Anatomy of T cell receptor binding of a H-2kd-associated photoreactive peptide derivative.
26. Differential roles of T cell receptor alpha and beta chains in ligand binding among H-2Kd-restricted cytolytic T lymphocyte clones specific for a photoreactive Plasmodium berghei circumsporozoite peptide derivative.
27. Binding of photoreactive lysozyme peptides to murine histocompatibility class II molecules.
28. HLA photoaffinity labeling reveals overlapping binding of homologous melanoma-associated gene peptides by HLA-A1, HLA-A29, and HLA-B44.
29. The efficiency of antigen recognition by CD8+CTL clones is determined by the frequency of serial TCR engagement
30. Soluble MHC-peptide complexes induce rapid death of CD8+ CTL1
31. Peptide modification or blocking of CD8, resulting in weak TCR signaling, can activate CTL for Fas- but not perforin-dependent cytotoxicity or cytokine production
32. Highly diverse T cell recognition of a single Plasmodium berghei peptide presented by a series of mutant H-2K(d) molecules
33. Immunization with synthetic peptides containing a defined malaria epitope induces a highly diverse cytotoxic t lymphocyte response: Evidence that two peptide residues are buried in the MHC molecule
34. ChemInform Abstract: PREPARATION AND CONFORMATIONAL PROPERTIES OF BENZYLPENICILLOYL-OLIGO-L-LYSINE CONJUGATES
35. ChemInform Abstract: DEBLOCKING OF O‐NITROPHENYLSULFENYL‐PROTECTED PEPTIDES BY AMMONIUM THIOCYANATE AND (2‐METHYL‐2‐INDOLYL)ACETIC ACID
36. ChemInform Abstract: POTENTIATION OF THE TOLEROGENICITY OF BENZYLPENICILLOYLATED EICOSA-L-LYSINE BY CONJUGATION WITH 4-METHOXYBENZYL 3β-CHOLESTANYL SUCCINATE
37. Oligomerization and ring closure of immunoglobulin E class antibodies by divalent haptens
38. Structural analysis of TCR-ligand interactions studied on H-2Kd-restricted cloned CTL specific for a photoreactive peptide derivative
39. Efficient in vivo induction of CTL by cell-associated covalent H-2K^d-peptide complexes
40. Probing the Conformational Dynamics of Affinity-Enhanced T Cell Receptor Variants upon Binding the Peptide-Bound Major Histocompatibility Complex by Hydrogen/Deuterium Exchange Mass Spectrometry.
41. The T-Cell Receptor Can Bind to the Peptide-Bound Major Histocompatibility Complex and Uncomplexed β 2 -Microglobulin through Distinct Binding Sites.
42. In silico and cell-based analyses reveal strong divergence between prediction and observation of T-cell-recognized tumor antigen T-cell epitopes.
43. Vaccination with LAG-3Ig (IMP321) and Peptides Induces Specific CD4 and CD8 T-Cell Responses in Metastatic Melanoma Patients--Report of a Phase I/IIa Clinical Trial.
44. Identification of Rare High-Avidity, Tumor-Reactive CD8+ T Cells by Monomeric TCR-Ligand Off-Rates Measurements on Living Cells.
45. Nonclassical antigen-processing pathways are required for MHC class II-restricted direct tumor recognition by NY-ESO-1-specific CD4(+) T cells.
46. Analysis, Isolation, and Activation of Antigen-Specific CD4(+) and CD8(+) T Cells by Soluble MHC-Peptide Complexes.
47. T cells maintain an exhausted phenotype after antigen withdrawal and population reexpansion.
48. Establishment of animal models to analyze the kinetics and distribution of human tumor antigen-specific CD8⁺ T cells.
49. MHC class II/ESO tetramer-based generation of in vitro primed anti-tumor T-helper lines for adoptive cell therapy of cancer.
50. Induction of CD8 T-cell responses restricted to multiple HLA class I alleles in a cancer patient by immunization with a 20-mer NY-ESO-1f (NY-ESO-1 91-110) peptide.
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.